Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Eniluracil may increase the effectiveness of chemotherapy by blocking tumor
enzymes that break down chemotherapy drugs.
PURPOSE: Randomized phase II trial to determine the effectiveness of eniluracil followed by
surgery in treating patients who have primary or metastatic colorectal cancer.